The detailed information on the locations of genomic alterations provided by the high-resolution CGH arrays used here allowed us to more clearly delineate the distinct genetic pathways undertaken by breast tumours displaying either BRCA1 or BRCA2 abnormalities. The gene discussed is BRCA1; the disease is breast neoplasm.